As a common biological buffer, Tris(Hydroxymethyl)Aminomethane
(TRIS) is not only widely used as a solvent for nucleic acids and
proteins, but also as one of the main components of protein
electrophoresis buffers. It can also produce a variety of chemicals and
pesticides, pharmaceutical products, and it is an important intermediate
for the preparation of surfactants, vulcanization accelerators and some
drugs. This article will introduce another role of TRIS——modified zein
functional drug-loaded microspheres.
As
a natural hydrophobic macromolecule, zein has a wide range of sources,
it is non-toxic, non-immunogenic, and has good biocompatibility and
biodegradability. It is one of the few hydrophobic biopolymers that are
allowed to be taken orally by the FDA:
(1) Its
amino acid composition is very special, the proportion of non-polar
amino acids is more than 50%. It can embed various substances such as
polysaccharides. DNA, RNA, proteins, metal nanoparticles, quantum dots,
oil droplets, and hydrophobic drugs;
(2) The
amino acid residues on zein carry certain polar groups (such as ‐SH,
‐COOH, ‐NH3, and ‐OH), it provides the possibility to graft various
functional molecules for chemical reaction sites and adapt to the
complex and varied human environment.
Therefore,
zein is an advantageous drug carrier material. However, the proportion
of sulphur-containing amino acids in zein is only 2.8%, the ratio of
basic amino acids is only 2.9%, and the proportion of hydroxyamino acids
is 13.4%, which limits the selection of functional molecules and the
effect of modification. To improve this, the researchers modified it
with TRIS, including the following steps [1]:
(1)
The zein and the amino protecting agent di-tert-butyl dicarbonate are
dissolved in a specific dimethyl sulfoxide or ethanol aqueous solution
at a mass ratio of 1:1~1.5:1, and protected from light at 25~40°C. The
reaction is carried out for 12~24 hours to obtain a zein protection
solution;
(2) Under the protection of nitrogen, add carbodiimide salt, N-hydroxysuccinimide and TRIS (CAS 77-86-1) to the zein protection solution, and avoid the light reaction at 25-40°C for 12~24 hours. To obtain a TRIS-zein solution;
(3)
under the protection of nitrogen, adding concentrated hydrochloric acid
to the tris-zein solution, and avoiding light reaction at 25-40°C for
6-8h;
(4)
adjusting the pH to 5.0~6.0, transferring to a dialysis bag,
centrifuging the retained solution in the dialysis bag, and lyophilizing
to obtain TRIS-zein;
(5)
Dissolving the hydrophobic drug and the lyophilized TRIS -zein in an
aqueous solution of ethanol at a mass ratio of 1:1 to 1:10; and
injecting hydrochloric acid having a pH of 2.5 to 4.5 under magnetic
stirring. In the aqueous solution, after stabilization, the supernatant
is centrifuged to obtain a drug-loaded microsphere;
(6)
Functional modification of drug-loaded microspheres: separately prepare
solutions containing different functional molecules, disperse the
drug-loaded microspheres into a solution containing functional
molecules, stir the reaction, centrifuge to remove the supernatant, and
obtain functional drug carrying microsphere. The drug microspheres have a
particle size of 100~300 nm and a drug-loading efficiency of
81.48~86.01%, and the grafting amount of the functional molecules is
1.72~1.94 times that of the unmodified zein microspheres.
The
coupling of TRIS to zein significantly improves the physicochemical
properties of zein. The prepared microspheres have good sphericity,
uniform particle size distribution, high drug-loading efficiency, and
are suitable for in vivo delivery. This research expands the application
of zein in drug delivery systems and has a good application prospect in
the field of medicine.
References
[1]
Jiang Yanbin, Pang Jiafeng, Lu Shan, Li Zhixian, Trimethylolamine
modified zein functional drug-loaded microspheres and preparation
method. 2018, CN108403662A.
Edited by Suzhou Yacoo Science Co., Ltd.
没有评论:
发表评论